Joris M van Montfrans
Overview
Explore the profile of Joris M van Montfrans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
981
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berbers R, Paganelli F, van Montfrans J, Ellerbroek P, Viveen M, Rogers M, et al.
Microbiome
. 2025 Jan;
13(1):12.
PMID: 39819634
Background: Common variable immunodeficiency (CVID) is characterized by hypogammaglobulinemia and recurrent infections. Significant morbidity and mortality are caused by immune dysregulation complications (CVIDid), which affect around one-third of CVID patients...
2.
Vallee T, Glasmacher J, Buchner H, Arkwright P, Behrends U, Bondarenko A, et al.
Blood
. 2024 Apr;
143(24):2504-2516.
PMID: 38579284
Wiskott-Aldrich syndrome (WAS) is a multifaceted monogenic disorder with a broad disease spectrum and variable disease severity and a variety of treatment options including allogeneic hematopoietic stem cell transplantation (HSCT)...
3.
Kemps P, Bruin M, Haasnoot A, van Egmond-Ebbeling M, Renson T, van Montfrans J
Lancet Rheumatol
. 2024 Jan;
4(6):e450.
PMID: 38293959
No abstract available.
4.
Hamad Saied M, van Straalen J, de Roock S, Verduyn Lunel F, Wit J, de Rond L, et al.
Vaccine
. 2024 Jan;
42(5):1145-1153.
PMID: 38262809
Objectives: To evaluate immunogenicity, effectiveness and safety of COVID-19 vaccination in patients with pediatric autoimmune inflammatory rheumatic disease (pedAIIRD). Methods: A prospective cohort study was performed at the pediatric rheumatology...
5.
Smits B, Boland S, Hol M, Dandis R, Leavis H, de Jong P, et al.
J Allergy Clin Immunol Pract
. 2024 Jan;
12(4):1037-1048.e3.
PMID: 38182096
Background: Patients with primary antibody deficiency (PAD) frequently suffer from pulmonary complications, associated with severe morbidity and mortality. Hence, regular pulmonary screening by computed tomography (CT) scanning is advised. However,...
6.
Verschoof M, van Meenen L, Andriessen M, Brinkman D, Kamphuis S, Kuijpers T, et al.
Eur J Neurol
. 2023 Aug;
31(1):e16043.
PMID: 37584090
Background And Purpose: Patients with adenosine deaminase 2 (ADA2) deficiency can present with various neurological manifestations due to vasculopathies and autoinflammation. These include ischaemic and hemorrhagic stroke, but less clearly...
7.
Antibody deficiencies in children are associated with prematurity and a family history of infections
Koenen M, van Montfrans J, Prevaes S, van Engelen M, van der Vries E, Boes M, et al.
Pediatr Res
. 2023 Jul;
94(6):2047-2053.
PMID: 37491587
Background: Recurrent respiratory tract infections (rRTIs) frequently affect young children and are associated with antibody deficiencies. We investigated the prevalence of and epidemiological risk factors associated with antibody deficiencies in...
8.
Andriessen M, Legger G, Bredius R, van Gijn M, Hak A, Hissink Muller P, et al.
J Clin Immunol
. 2023 Jun;
43(7):1581-1596.
PMID: 37277582
Deficiency of adenosine deaminase-2 (DADA2) is an autosomal recessive autoinflammatory disease with an extremely variable disease presentation. This paper provides a comprehensive overview of the Dutch DADA2 cohort. We performed...
9.
Lee P, Davidson B, Abraham R, Alter B, Arostegui J, Bell K, et al.
JAMA Netw Open
. 2023 May;
6(5):e2315894.
PMID: 37256629
Importance: Deficiency of adenosine deaminase 2 (DADA2) is a recessively inherited disease characterized by systemic vasculitis, early-onset stroke, bone marrow failure, and/or immunodeficiency affecting both children and adults. DADA2 is...
10.
Messelink M, Berbers R, van Montfrans J, Ellerbroek P, Gladiator A, Welsing P, et al.
Allergy Asthma Clin Immunol
. 2023 May;
19(1):44.
PMID: 37245042
Background: Primary antibody deficiencies (PAD) are characterized by a heterogeneous clinical presentation and low prevalence, contributing to a median diagnostic delay of 3-10 years. This increases the risk of morbidity...